Markers of oxidative stress in umbilical cord blood from G6PD deficient African newborns.
Paul S StademMegan V HilgersDerrick BengoSarah E CusickSusan NdiddeTina M SlusherTroy C LundPublished in: PloS one (2017)
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked disorder that affects as many as 400 million people worldwide, making it the most common enzymatic defect. Subjects with G6PD deficiency are more likely to develop neonatal hyperbilirubinemia potentially leading to kernicterus and are at increased risk for acute hemolytic anemia when exposed to pro-oxidant compounds such as anti-malarial drugs. We collected umbilical cord blood from 300 males born in Uganda to assess for novel markers of systemic oxidative stress. We determined that 10.7% of the samples collected were G6PD A- deficient (G202A/A376G) and when these were compared with unaffected controls, there was significantly higher 8-hydroxy-2'-deoxyguanosine (8-OHdG) concentration, elevated ferritin, increased leukocyte count and higher small molecule antioxidant capacity. These data suggest increased baseline oxidative stress and an elevated antioxidant response in umbilical cord blood of patients with G6PD deficiency.
Keyphrases
- umbilical cord
- mesenchymal stem cells
- oxidative stress
- small molecule
- dna damage
- diabetic rats
- ischemia reperfusion injury
- bone marrow
- induced apoptosis
- anti inflammatory
- pregnant women
- chronic kidney disease
- type diabetes
- liver failure
- gestational age
- low birth weight
- machine learning
- protein protein
- electronic health record
- blood glucose
- nitric oxide
- blood pressure
- peripheral blood
- big data
- artificial intelligence
- cord blood
- insulin resistance
- hydrogen peroxide
- deep learning
- preterm infants
- skeletal muscle
- preterm birth
- extracorporeal membrane oxygenation